PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.

Mouse / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28028070 ↗2016Reported benefit

Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.

MouseOtherC57BL/6Male

Model: Photochemical injury of the common carotid artery producing arterial thrombosis; complementary in vitro work used human aortic endothelial cells stimulated with tumour necrosis factor-alpha

Ticagrelor prolonged time to arterial occlusion compared with clopidogrel despite comparable antiplatelet effects, and reduced tissue factor expression in the endothelium of murine arteries. In human aortic endothelial cells ticagrelor, but not clopidogrel active metabolite, reduced TNF-alpha-induc…

Extraction: extract · Supplied extraction confidence: 0.72. Machine-extracted fields require source verification.